Klivira
Request demo

Automating Physical Therapy Specialty Drug Prior Auth for Efficient Patient Care

Klivira empowers physical therapy practices and integrated health systems to efficiently manage **physical therapy specialty drug prior auth**, ensuring patients access critical high-cost therapies without unnecessary delays.

For revenue cycle directors and prior authorization coordinators within physical therapy departments, navigating specialty drug prior authorizations presents unique challenges. While PT primarily focuses on non-pharmacological interventions, many patients undergoing physical therapy require concurrent specialty medications for conditions like inflammatory arthritis, complex pain syndromes, or post-surgical recovery, demanding a robust and integrated PA workflow.

The Intersection of Physical Therapy and Specialty Drug Management

Physical therapy often serves patients with complex conditions, including autoimmune disorders, severe orthopedic injuries, or chronic neuropathic pain, where high-cost specialty drugs like biologics or advanced pain management therapies are integral to their overall treatment plan. Ensuring timely access to these medications is crucial for optimizing patient outcomes and facilitating effective physical rehabilitation, yet the PA process can be a significant bottleneck.

Key Prior Authorization Triggers for Specialty Drugs in PT Patient Pathways

  • Biologics and biosimilars for inflammatory conditions (e.g., rheumatoid arthritis, psoriatic arthritis) managed with physical therapy.
  • Specialty injectables or oral targeted therapies for complex pain syndromes or neurological conditions where PT is a primary intervention.
  • High-cost infused medications administered in conjunction with post-surgical rehabilitation.
  • Medications requiring site-of-care optimization for administration, impacting the patient's overall care coordination.
  • Drugs prescribed for conditions that necessitate extensive visit-cap exceptions or post-surgical authorizations for physical therapy itself.

Navigating the Complexities of Specialty Drug Prior Auth

Specialty drug prior authorization is inherently complex, often requiring precise benefit-side determination (medical vs. pharmacy), extensive clinical documentation for step-therapy requirements, and adherence to specific site-of-care policies. Misclassification or incomplete submissions lead to delays and denials, directly impacting patient adherence and the continuity of their physical therapy regimen.

Klivira's Automated Approach to Physical Therapy Specialty Drug Prior Auth

Klivira streamlines the **physical therapy specialty drug prior auth** process by automating critical steps from prescription to fulfillment. Our platform intelligently determines whether a specialty drug falls under the medical or pharmacy benefit, routing submissions through the appropriate channels, including NCPDP SCRIPT ePA for pharmacy benefits and X12 278 or Da Vinci PAS for medical benefits.

Enhanced Efficiency Through Integrated Automation

  • **Automated Benefit-Side Determination**: Klivira's policy engine accurately identifies the correct medical or pharmacy benefit path per drug, payer, and patient context, eliminating misclassification errors.
  • **Intelligent Documentation Assembly**: The platform leverages FHIR MedicationRequest and Observation resources from EMRs to automatically populate step-therapy requirements and prior-line therapy history.
  • **Site-of-Care Policy Alignment**: Klivira integrates payer site-of-care policies, flagging potential mismatches before submission for infused specialty drugs relevant to PT patients.
  • **Seamless Specialty Pharmacy Handoff**: For pharmacy-benefit drugs, Klivira coordinates the post-approval fulfillment workflow with specialty pharmacy partners.
  • **Copay Assistance Guidance**: The system identifies manufacturer copay assistance program availability and flags Medicare patient exclusions for compliance considerations.

Optimizing EMR and Payer Interactions for PT Practices

Klivira integrates directly with leading EMR systems via SMART on FHIR, capturing necessary clinical data for specialty drug PAs. Our multi-channel connectivity ensures submissions reach payers through their preferred and most efficient pathways, including established ePA partners (CoverMyMeds, Surescripts), X12 278 EDI, and Da Vinci PAS, minimizing manual data entry and accelerating approval times for PT patients.

Frequently asked questions

How does Klivira handle the medical vs. pharmacy benefit split for specialty drugs relevant to physical therapy patients?

Klivira's policy engine automatically determines whether a specialty drug for a PT patient falls under the medical or pharmacy benefit based on the specific drug, payer, and patient context. This ensures the prior authorization request is routed to the correct channel, utilizing NCPDP SCRIPT ePA for pharmacy benefits and X12 278 or Da Vinci PAS for medical benefits.

What EMR data does Klivira leverage for specialty drug prior authorizations in physical therapy settings?

Klivira integrates with EMRs using SMART on FHIR to access relevant clinical documentation. For specialty drug PAs, this includes FHIR MedicationRequest for prescription details and Observation resources for treatment response data, enabling automated population of step-therapy and prior-line therapy requirements.

Can Klivira assist with site-of-care requirements for infused specialty drugs prescribed to physical therapy patients?

Yes, Klivira's platform incorporates payer site-of-care policies. For infused specialty drugs, it surfaces site-of-care information aligned with payer requirements and flags potential policy mismatches before submission, helping PT practices avoid denials related to incorrect administration locations.

Does Klivira coordinate with specialty pharmacies for post-approval fulfillment of drugs for PT patients?

For pharmacy-benefit specialty drugs, Klivira coordinates the post-approval specialty pharmacy fulfillment workflow. While Klivira doesn't directly manage logistics, it streamlines the handoff process to specialty pharmacy partners, aiming to reduce delays in time-to-medication for physical therapy patients.

How does Klivira help physical therapy practices manage manufacturer copay assistance programs for specialty drugs?

Klivira's workflow identifies the availability of manufacturer copay assistance programs for specialty drugs. It also flags specific exclusions, such as for Medicare patients, to ensure compliance with relevant regulations and inform the patient financial navigation process within the physical therapy setting.

Related coverage

Other physical-therapy prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo